Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

Atlantic City, N.J.? Merck & Co. won its first court battle over its Vioxx painkiller Thursday when a New Jersey state jury found that the drugmaker properly warned consumers about the risks of ...

Merck argues shareholders, who filed suit in November 2003, waited too long to sue. The case, involving the drug Vioxx, could have far-reaching impact, as the question presented was when ...

Cardiovasc Rev Rep. 2004;25(6):288-290. The recent sudden withdrawal of Vioxx (rofecoxib; Merck & Co., Whitehouse Station, NJ) from the market owing to safety concerns has created considerable ...

When Merck & Co. withdrew the painkiller Vioxx from the market last September after the drug was linked to increased risks of heart attack and stroke, more than one metabolomics researcher shook their ...

Triggered by concerns over an increased risk of cardiovascular side effects, Merck announced on 30 September the withdrawal of rofecoxib (Vioxx), its leading drug for the management of rheumatoid ...

Although Merck (Vioxx) invested in nearly twice as many ads as Pfizer (Celebrex) for the first nine months of 2000, advertising exposure for the two brands was roughly comparable over the ...